nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—Melphalan—Chlorambucil—testicular cancer	0.447	1	CrCrCtD
Ibuprofen—SLCO1A2—Chlorambucil—testicular cancer	0.0516	0.139	CbGbCtD
Ibuprofen—UGT2B7—Epirubicin—testicular cancer	0.0283	0.0762	CbGbCtD
Ibuprofen—ABCC1—Dactinomycin—testicular cancer	0.0278	0.0748	CbGbCtD
Ibuprofen—PTGS1—Ifosfamide—testicular cancer	0.0203	0.0545	CbGbCtD
Ibuprofen—ABCC1—Epirubicin—testicular cancer	0.0201	0.0542	CbGbCtD
Ibuprofen—UGT1A1—Etoposide—testicular cancer	0.0191	0.0513	CbGbCtD
Ibuprofen—CFTR—vas deferens—testicular cancer	0.0175	0.339	CbGeAlD
Ibuprofen—ABCC1—Vinblastine—testicular cancer	0.0174	0.0468	CbGbCtD
Ibuprofen—ABCC1—Etoposide—testicular cancer	0.0157	0.0422	CbGbCtD
Ibuprofen—SLC22A11—Methotrexate—testicular cancer	0.0138	0.0373	CbGbCtD
Ibuprofen—ABCC4—Methotrexate—testicular cancer	0.0129	0.0347	CbGbCtD
Ibuprofen—CYP2C8—Ifosfamide—testicular cancer	0.0117	0.0315	CbGbCtD
Ibuprofen—PTGS2—Cisplatin—testicular cancer	0.0117	0.0314	CbGbCtD
Ibuprofen—PTGS2—Etoposide—testicular cancer	0.0115	0.0309	CbGbCtD
Ibuprofen—ABCC1—Doxorubicin—testicular cancer	0.0107	0.0288	CbGbCtD
Ibuprofen—ABCC1—Methotrexate—testicular cancer	0.0104	0.0279	CbGbCtD
Ibuprofen—CYP2C19—Ifosfamide—testicular cancer	0.00981	0.0264	CbGbCtD
Ibuprofen—PTGS1—Etoposide—testicular cancer	0.00969	0.0261	CbGbCtD
Ibuprofen—SLCO1A2—Methotrexate—testicular cancer	0.00925	0.0249	CbGbCtD
Ibuprofen—CYP2C9—Ifosfamide—testicular cancer	0.00816	0.022	CbGbCtD
Ibuprofen—SLC22A8—Methotrexate—testicular cancer	0.00806	0.0217	CbGbCtD
Ibuprofen—ABCB1—Dactinomycin—testicular cancer	0.0067	0.018	CbGbCtD
Ibuprofen—CFTR—semen—testicular cancer	0.00622	0.121	CbGeAlD
Ibuprofen—SLC22A6—Methotrexate—testicular cancer	0.00561	0.0151	CbGbCtD
Ibuprofen—CYP2C8—Etoposide—testicular cancer	0.00559	0.015	CbGbCtD
Ibuprofen—ALB—Methotrexate—testicular cancer	0.00478	0.0129	CbGbCtD
Ibuprofen—ABCB1—Vinblastine—testicular cancer	0.0042	0.0113	CbGbCtD
Ibuprofen—CYP2C9—Cisplatin—testicular cancer	0.00397	0.0107	CbGbCtD
Ibuprofen—ABCB1—Cisplatin—testicular cancer	0.00385	0.0104	CbGbCtD
Ibuprofen—ABCB1—Etoposide—testicular cancer	0.00378	0.0102	CbGbCtD
Ibuprofen—FABP2—embryo—testicular cancer	0.00308	0.0598	CbGeAlD
Ibuprofen—ABCB1—Doxorubicin—testicular cancer	0.00258	0.00695	CbGbCtD
Ibuprofen—ABCB1—Methotrexate—testicular cancer	0.0025	0.00673	CbGbCtD
Ibuprofen—THBD—gonad—testicular cancer	0.00134	0.026	CbGeAlD
Ibuprofen—CFTR—seminal vesicle—testicular cancer	0.00132	0.0256	CbGeAlD
Ibuprofen—PLAT—seminal vesicle—testicular cancer	0.0013	0.0253	CbGeAlD
Ibuprofen—PPARG—Teniposide—Etoposide—testicular cancer	0.00111	1	CbGdCrCtD
Ibuprofen—FABP2—lymph node—testicular cancer	0.00109	0.0212	CbGeAlD
Ibuprofen—THBD—female gonad—testicular cancer	0.00109	0.0211	CbGeAlD
Ibuprofen—THBD—testis—testicular cancer	0.000964	0.0187	CbGeAlD
Ibuprofen—BCL2—gonad—testicular cancer	0.000942	0.0183	CbGeAlD
Ibuprofen—THBD—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—testicular cancer	0.000867	0.0376	CbGpPWpGaD
Ibuprofen—PLAT—NOTCH1 regulation of human endothelial cell calcification—FGFR3—testicular cancer	0.000864	0.0375	CbGpPWpGaD
Ibuprofen—CFTR—female gonad—testicular cancer	0.000775	0.0151	CbGeAlD
Ibuprofen—PLAT—female gonad—testicular cancer	0.000765	0.0149	CbGeAlD
Ibuprofen—BCL2—female gonad—testicular cancer	0.000765	0.0149	CbGeAlD
Ibuprofen—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000731	0.0317	CbGpPWpGaD
Ibuprofen—CXCL8—female gonad—testicular cancer	0.000709	0.0138	CbGeAlD
Ibuprofen—THBD—lymph node—testicular cancer	0.000698	0.0136	CbGeAlD
Ibuprofen—CFTR—testis—testicular cancer	0.000687	0.0134	CbGeAlD
Ibuprofen—PLAT—testis—testicular cancer	0.000679	0.0132	CbGeAlD
Ibuprofen—BCL2—testis—testicular cancer	0.000679	0.0132	CbGeAlD
Ibuprofen—PPARG—embryo—testicular cancer	0.000667	0.013	CbGeAlD
Ibuprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.000643	0.0279	CbGpPWpGaD
Ibuprofen—CXCL8—testis—testicular cancer	0.000629	0.0122	CbGeAlD
Ibuprofen—CFTR—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000559	0.0243	CbGpPWpGaD
Ibuprofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000557	0.0242	CbGpPWpGaD
Ibuprofen—UGT2B7—testis—testicular cancer	0.000535	0.0104	CbGeAlD
Ibuprofen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00051	0.0222	CbGpPWpGaD
Ibuprofen—PLAT—lymph node—testicular cancer	0.000492	0.00956	CbGeAlD
Ibuprofen—BCL2—lymph node—testicular cancer	0.000492	0.00956	CbGeAlD
Ibuprofen—UGT2B4—Phase II conjugation—HPGDS—testicular cancer	0.000489	0.0213	CbGpPWpGaD
Ibuprofen—ABCC1—seminal vesicle—testicular cancer	0.000485	0.00942	CbGeAlD
Ibuprofen—UGT1A3—NRF2 pathway—SLC2A6—testicular cancer	0.000482	0.0209	CbGpPWpGaD
Ibuprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000465	0.0202	CbGpPWpGaD
Ibuprofen—CXCL8—lymph node—testicular cancer	0.000456	0.00885	CbGeAlD
Ibuprofen—ABCC4—Ectoderm Differentiation—TFAP2C—testicular cancer	0.000441	0.0191	CbGpPWpGaD
Ibuprofen—PLAT—amb2 Integrin signaling—MMP2—testicular cancer	0.000424	0.0184	CbGpPWpGaD
Ibuprofen—CXCL8—Syndecan-3-mediated signaling events—FGFR3—testicular cancer	0.000421	0.0183	CbGpPWpGaD
Ibuprofen—UGT2B7—NRF2 pathway—SLC2A6—testicular cancer	0.00041	0.0178	CbGpPWpGaD
Ibuprofen—ABCC4—NRF2 pathway—SLC2A6—testicular cancer	0.000385	0.0167	CbGpPWpGaD
Ibuprofen—SLCO2B1—female gonad—testicular cancer	0.000377	0.00732	CbGeAlD
Ibuprofen—PPARG—female gonad—testicular cancer	0.000368	0.00714	CbGeAlD
Ibuprofen—SLCO2B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000366	0.0159	CbGpPWpGaD
Ibuprofen—PTGS2—embryo—testicular cancer	0.000341	0.00662	CbGeAlD
Ibuprofen—PTGS1—seminal vesicle—testicular cancer	0.000335	0.0065	CbGeAlD
Ibuprofen—SLCO2B1—testis—testicular cancer	0.000334	0.0065	CbGeAlD
Ibuprofen—ABCC4—female gonad—testicular cancer	0.000334	0.00649	CbGeAlD
Ibuprofen—UGT1A1—NRF2 pathway—SLC2A6—testicular cancer	0.000333	0.0145	CbGpPWpGaD
Ibuprofen—UGT1A9—NRF2 pathway—SLC2A6—testicular cancer	0.000333	0.0145	CbGpPWpGaD
Ibuprofen—SLC22A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000332	0.0144	CbGpPWpGaD
Ibuprofen—CXCL8—Peptide ligand-binding receptors—INSL3—testicular cancer	0.00033	0.0143	CbGpPWpGaD
Ibuprofen—PPARG—testis—testicular cancer	0.000326	0.00634	CbGeAlD
Ibuprofen—PTGS2—seminal vesicle—testicular cancer	0.00032	0.00622	CbGeAlD
Ibuprofen—CXCL8—Bladder Cancer—FGFR3—testicular cancer	0.000308	0.0134	CbGpPWpGaD
Ibuprofen—SLCO1A2—testis—testicular cancer	0.000308	0.00598	CbGeAlD
Ibuprofen—ALB—testis—testicular cancer	0.000306	0.00594	CbGeAlD
Ibuprofen—BCL2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000303	0.0132	CbGpPWpGaD
Ibuprofen—PLAT—Endochondral Ossification—FGFR3—testicular cancer	0.000299	0.013	CbGpPWpGaD
Ibuprofen—ABCC4—testis—testicular cancer	0.000296	0.00575	CbGeAlD
Ibuprofen—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—KITLG—testicular cancer	0.00029	0.0126	CbGpPWpGaD
Ibuprofen—UGT2B4—Biological oxidations—HPGDS—testicular cancer	0.000286	0.0124	CbGpPWpGaD
Ibuprofen—ABCC1—female gonad—testicular cancer	0.000285	0.00553	CbGeAlD
Ibuprofen—ABCC1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000275	0.0119	CbGpPWpGaD
Ibuprofen—CXCL8—Syndecan-2-mediated signaling events—FGFR3—testicular cancer	0.000273	0.0119	CbGpPWpGaD
Ibuprofen—PLAT—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000273	0.0119	CbGpPWpGaD
Ibuprofen—UGT1A3—Phase II conjugation—HPGDS—testicular cancer	0.000262	0.0114	CbGpPWpGaD
Ibuprofen—BCL2—Kit receptor signaling pathway—KITLG—testicular cancer	0.000258	0.0112	CbGpPWpGaD
Ibuprofen—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000253	0.011	CbGpPWpGaD
Ibuprofen—ABCC1—testis—testicular cancer	0.000253	0.00491	CbGeAlD
Ibuprofen—SLCO2B1—lymph node—testicular cancer	0.000242	0.00471	CbGeAlD
Ibuprofen—PPARG—lymph node—testicular cancer	0.000236	0.00459	CbGeAlD
Ibuprofen—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000232	0.0101	CbGpPWpGaD
Ibuprofen—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000225	0.00977	CbGpPWpGaD
Ibuprofen—UGT2B7—Phase II conjugation—HPGDS—testicular cancer	0.000223	0.00968	CbGpPWpGaD
Ibuprofen—CXCL8—Syndecan-2-mediated signaling events—MMP2—testicular cancer	0.000222	0.00966	CbGpPWpGaD
Ibuprofen—ALB—lymph node—testicular cancer	0.000222	0.00431	CbGeAlD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000221	0.00962	CbGpPWpGaD
Ibuprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—testicular cancer	0.000218	0.00945	CbGpPWpGaD
Ibuprofen—CYP2C8—testis—testicular cancer	0.000215	0.00418	CbGeAlD
Ibuprofen—ABCC4—lymph node—testicular cancer	0.000215	0.00417	CbGeAlD
Ibuprofen—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000211	0.00918	CbGpPWpGaD
Ibuprofen—BCL2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000211	0.00918	CbGpPWpGaD
Ibuprofen—ABCB1—embryo—testicular cancer	0.000211	0.00409	CbGeAlD
Ibuprofen—ABCB1—seminal vesicle—testicular cancer	0.000198	0.00385	CbGeAlD
Ibuprofen—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—KIT—testicular cancer	0.000198	0.00859	CbGpPWpGaD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000197	0.00856	CbGpPWpGaD
Ibuprofen—PTGS1—female gonad—testicular cancer	0.000197	0.00382	CbGeAlD
Ibuprofen—BCL2—C-MYB transcription factor network—KITLG—testicular cancer	0.000194	0.00844	CbGpPWpGaD
Ibuprofen—PTGS2—female gonad—testicular cancer	0.000188	0.00365	CbGeAlD
Ibuprofen—SLCO2B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000186	0.00809	CbGpPWpGaD
Ibuprofen—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000184	0.008	CbGpPWpGaD
Ibuprofen—ABCC1—lymph node—testicular cancer	0.000183	0.00356	CbGeAlD
Ibuprofen—UGT1A1—Phase II conjugation—HPGDS—testicular cancer	0.000181	0.00787	CbGpPWpGaD
Ibuprofen—UGT1A9—Phase II conjugation—HPGDS—testicular cancer	0.000181	0.00787	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—PRDM14—testicular cancer	0.000179	0.00779	CbGpPWpGaD
Ibuprofen—BCL2—Kit receptor signaling pathway—KIT—testicular cancer	0.000176	0.00764	CbGpPWpGaD
Ibuprofen—PLAT—Signaling by PDGF—KITLG—testicular cancer	0.000174	0.00758	CbGpPWpGaD
Ibuprofen—PTGS1—testis—testicular cancer	0.000174	0.00339	CbGeAlD
Ibuprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—H2AFZ—testicular cancer	0.00017	0.00738	CbGpPWpGaD
Ibuprofen—SLC22A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000169	0.00733	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—INSL3—testicular cancer	0.000169	0.00732	CbGpPWpGaD
Ibuprofen—BCL2—ATF-2 transcription factor network—MMP2—testicular cancer	0.000156	0.00677	CbGpPWpGaD
Ibuprofen—UGT1A3—Biological oxidations—HPGDS—testicular cancer	0.000153	0.00666	CbGpPWpGaD
Ibuprofen—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00015	0.00651	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.00015	0.00651	CbGpPWpGaD
Ibuprofen—CXCL8—ATF-2 transcription factor network—MMP2—testicular cancer	0.00015	0.00651	CbGpPWpGaD
Ibuprofen—ABCB1—gonad—testicular cancer	0.000143	0.00278	CbGeAlD
Ibuprofen—CXCL8—LPA receptor mediated events—MMP2—testicular cancer	0.00014	0.0061	CbGpPWpGaD
Ibuprofen—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000134	0.00581	CbGpPWpGaD
Ibuprofen—BCL2—C-MYB transcription factor network—KIT—testicular cancer	0.000133	0.00576	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—STK11—testicular cancer	0.000131	0.00571	CbGpPWpGaD
Ibuprofen—UGT2B7—Biological oxidations—HPGDS—testicular cancer	0.00013	0.00567	CbGpPWpGaD
Ibuprofen—PLAT—Signaling by PDGF—FGFR3—testicular cancer	0.00013	0.00563	CbGpPWpGaD
Ibuprofen—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000129	0.00559	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000128	0.00554	CbGpPWpGaD
Ibuprofen—PTGS1—lymph node—testicular cancer	0.000126	0.00246	CbGeAlD
Ibuprofen—ABCC4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000123	0.00536	CbGpPWpGaD
Ibuprofen—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000122	0.0053	CbGpPWpGaD
Ibuprofen—PTGS2—lymph node—testicular cancer	0.000121	0.00235	CbGeAlD
Ibuprofen—PLAT—Signaling by PDGF—KIT—testicular cancer	0.000119	0.00517	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.000117	0.0051	CbGpPWpGaD
Ibuprofen—ABCB1—female gonad—testicular cancer	0.000116	0.00226	CbGeAlD
Ibuprofen—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000114	0.00496	CbGpPWpGaD
Ibuprofen—ALB—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00011	0.00477	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000109	0.00473	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular Senescence—H2AFZ—testicular cancer	0.000107	0.00467	CbGpPWpGaD
Ibuprofen—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000107	0.00466	CbGpPWpGaD
Ibuprofen—UGT1A1—Biological oxidations—HPGDS—testicular cancer	0.000106	0.0046	CbGpPWpGaD
Ibuprofen—UGT1A9—Biological oxidations—HPGDS—testicular cancer	0.000106	0.0046	CbGpPWpGaD
Ibuprofen—ABCB1—testis—testicular cancer	0.000103	0.002	CbGeAlD
Ibuprofen—ABCC1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000103	0.00447	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—INSL3—testicular cancer	9.53e-05	0.00414	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	8.89e-05	0.00386	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—INSL3—testicular cancer	8.86e-05	0.00385	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—INSL3—testicular cancer	8.65e-05	0.00376	CbGpPWpGaD
Ibuprofen—PTGS1—Biological oxidations—HPGDS—testicular cancer	8.64e-05	0.00375	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	8.18e-05	0.00355	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—H2AFZ—testicular cancer	8.12e-05	0.00353	CbGpPWpGaD
Ibuprofen—BCL2—Direct p53 effectors—MMP2—testicular cancer	7.81e-05	0.00339	CbGpPWpGaD
Ibuprofen—ABCB1—lymph node—testicular cancer	7.47e-05	0.00145	CbGeAlD
Ibuprofen—BCL2—Innate Immune System—BCL10—testicular cancer	6.9e-05	0.003	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	6.31e-05	0.00274	CbGpPWpGaD
Ibuprofen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	6.09e-05	0.00265	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—DNMT3L—testicular cancer	5.66e-05	0.00246	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	5.58e-05	0.00242	CbGpPWpGaD
Ibuprofen—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.58e-05	0.00242	CbGpPWpGaD
Ibuprofen—CYP2C8—Biological oxidations—HPGDS—testicular cancer	5.58e-05	0.00242	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—INSL3—testicular cancer	5.11e-05	0.00222	CbGpPWpGaD
Ibuprofen—Drowsiness—Doxorubicin—testicular cancer	5.04e-05	0.000477	CcSEcCtD
Ibuprofen—Visual impairment—Methotrexate—testicular cancer	5.04e-05	0.000476	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	5e-05	0.000473	CcSEcCtD
Ibuprofen—Vomiting—Ifosfamide—testicular cancer	4.99e-05	0.000472	CcSEcCtD
Ibuprofen—Hypersensitivity—Cisplatin—testicular cancer	4.98e-05	0.000472	CcSEcCtD
Ibuprofen—CYP2C19—Biological oxidations—HPGDS—testicular cancer	4.98e-05	0.00216	CbGpPWpGaD
Ibuprofen—Renal failure—Doxorubicin—testicular cancer	4.95e-05	0.000469	CcSEcCtD
Ibuprofen—Rash—Ifosfamide—testicular cancer	4.95e-05	0.000468	CcSEcCtD
Ibuprofen—Dermatitis—Ifosfamide—testicular cancer	4.94e-05	0.000468	CcSEcCtD
Ibuprofen—Erythema multiforme—Methotrexate—testicular cancer	4.94e-05	0.000467	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Doxorubicin—testicular cancer	4.94e-05	0.000467	CcSEcCtD
Ibuprofen—Urticaria—Etoposide—testicular cancer	4.92e-05	0.000466	CcSEcCtD
Ibuprofen—Haemoglobin—Epirubicin—testicular cancer	4.91e-05	0.000465	CcSEcCtD
Ibuprofen—Jaundice—Doxorubicin—testicular cancer	4.91e-05	0.000465	CcSEcCtD
Ibuprofen—Stomatitis—Doxorubicin—testicular cancer	4.91e-05	0.000465	CcSEcCtD
Ibuprofen—Rhinitis—Epirubicin—testicular cancer	4.9e-05	0.000464	CcSEcCtD
Ibuprofen—Abdominal pain—Etoposide—testicular cancer	4.9e-05	0.000464	CcSEcCtD
Ibuprofen—Urinary tract infection—Doxorubicin—testicular cancer	4.9e-05	0.000464	CcSEcCtD
Ibuprofen—Conjunctivitis—Doxorubicin—testicular cancer	4.9e-05	0.000464	CcSEcCtD
Ibuprofen—UGT2B4—Metabolism—HPGDS—testicular cancer	4.9e-05	0.00213	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.89e-05	0.00212	CbGpPWpGaD
Ibuprofen—Hepatitis—Epirubicin—testicular cancer	4.89e-05	0.000463	CcSEcCtD
Ibuprofen—Haemorrhage—Epirubicin—testicular cancer	4.89e-05	0.000463	CcSEcCtD
Ibuprofen—Tinnitus—Methotrexate—testicular cancer	4.87e-05	0.000461	CcSEcCtD
Ibuprofen—Asthenia—Cisplatin—testicular cancer	4.85e-05	0.000459	CcSEcCtD
Ibuprofen—Pharyngitis—Epirubicin—testicular cancer	4.85e-05	0.000459	CcSEcCtD
Ibuprofen—Sweating—Doxorubicin—testicular cancer	4.83e-05	0.000457	CcSEcCtD
Ibuprofen—Urinary tract disorder—Epirubicin—testicular cancer	4.83e-05	0.000457	CcSEcCtD
Ibuprofen—Oedema peripheral—Epirubicin—testicular cancer	4.82e-05	0.000456	CcSEcCtD
Ibuprofen—Haematuria—Doxorubicin—testicular cancer	4.81e-05	0.000455	CcSEcCtD
Ibuprofen—Urethral disorder—Epirubicin—testicular cancer	4.79e-05	0.000454	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Doxorubicin—testicular cancer	4.77e-05	0.000451	CcSEcCtD
Ibuprofen—Epistaxis—Doxorubicin—testicular cancer	4.75e-05	0.00045	CcSEcCtD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.74e-05	0.00206	CbGpPWpGaD
Ibuprofen—Sinusitis—Doxorubicin—testicular cancer	4.73e-05	0.000447	CcSEcCtD
Ibuprofen—Immune system disorder—Methotrexate—testicular cancer	4.72e-05	0.000447	CcSEcCtD
Ibuprofen—Visual impairment—Epirubicin—testicular cancer	4.71e-05	0.000446	CcSEcCtD
Ibuprofen—Mediastinal disorder—Methotrexate—testicular cancer	4.71e-05	0.000446	CcSEcCtD
Ibuprofen—Agranulocytosis—Doxorubicin—testicular cancer	4.7e-05	0.000445	CcSEcCtD
Ibuprofen—Chills—Methotrexate—testicular cancer	4.69e-05	0.000444	CcSEcCtD
Ibuprofen—Nausea—Ifosfamide—testicular cancer	4.66e-05	0.000441	CcSEcCtD
Ibuprofen—Diarrhoea—Cisplatin—testicular cancer	4.63e-05	0.000438	CcSEcCtD
Ibuprofen—Erythema multiforme—Epirubicin—testicular cancer	4.62e-05	0.000438	CcSEcCtD
Ibuprofen—Alopecia—Methotrexate—testicular cancer	4.62e-05	0.000437	CcSEcCtD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	4.58e-05	0.00199	CbGpPWpGaD
Ibuprofen—Mental disorder—Methotrexate—testicular cancer	4.58e-05	0.000433	CcSEcCtD
Ibuprofen—Hypersensitivity—Etoposide—testicular cancer	4.57e-05	0.000432	CcSEcCtD
Ibuprofen—Tinnitus—Epirubicin—testicular cancer	4.56e-05	0.000431	CcSEcCtD
Ibuprofen—Erythema—Methotrexate—testicular cancer	4.55e-05	0.00043	CcSEcCtD
Ibuprofen—Malnutrition—Methotrexate—testicular cancer	4.55e-05	0.00043	CcSEcCtD
Ibuprofen—Haemoglobin—Doxorubicin—testicular cancer	4.55e-05	0.00043	CcSEcCtD
Ibuprofen—CYP2C9—Biological oxidations—HPGDS—testicular cancer	4.54e-05	0.00197	CbGpPWpGaD
Ibuprofen—Rhinitis—Doxorubicin—testicular cancer	4.54e-05	0.000429	CcSEcCtD
Ibuprofen—Hepatitis—Doxorubicin—testicular cancer	4.52e-05	0.000428	CcSEcCtD
Ibuprofen—Haemorrhage—Doxorubicin—testicular cancer	4.52e-05	0.000428	CcSEcCtD
Ibuprofen—Pharyngitis—Doxorubicin—testicular cancer	4.49e-05	0.000425	CcSEcCtD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	4.47e-05	0.00194	CbGpPWpGaD
Ibuprofen—Urinary tract disorder—Doxorubicin—testicular cancer	4.47e-05	0.000423	CcSEcCtD
Ibuprofen—Oedema peripheral—Doxorubicin—testicular cancer	4.46e-05	0.000422	CcSEcCtD
Ibuprofen—Dysgeusia—Methotrexate—testicular cancer	4.45e-05	0.000421	CcSEcCtD
Ibuprofen—Asthenia—Etoposide—testicular cancer	4.45e-05	0.000421	CcSEcCtD
Ibuprofen—Urethral disorder—Doxorubicin—testicular cancer	4.43e-05	0.00042	CcSEcCtD
Ibuprofen—Immune system disorder—Epirubicin—testicular cancer	4.42e-05	0.000418	CcSEcCtD
Ibuprofen—Mediastinal disorder—Epirubicin—testicular cancer	4.41e-05	0.000417	CcSEcCtD
Ibuprofen—Chills—Epirubicin—testicular cancer	4.39e-05	0.000415	CcSEcCtD
Ibuprofen—Pruritus—Etoposide—testicular cancer	4.38e-05	0.000415	CcSEcCtD
Ibuprofen—Arrhythmia—Epirubicin—testicular cancer	4.37e-05	0.000413	CcSEcCtD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.36e-05	0.00189	CbGpPWpGaD
Ibuprofen—Visual impairment—Doxorubicin—testicular cancer	4.36e-05	0.000413	CcSEcCtD
Ibuprofen—Alopecia—Epirubicin—testicular cancer	4.32e-05	0.000409	CcSEcCtD
Ibuprofen—Vomiting—Cisplatin—testicular cancer	4.3e-05	0.000407	CcSEcCtD
Ibuprofen—Vision blurred—Methotrexate—testicular cancer	4.29e-05	0.000406	CcSEcCtD
Ibuprofen—Mental disorder—Epirubicin—testicular cancer	4.28e-05	0.000405	CcSEcCtD
Ibuprofen—Erythema multiforme—Doxorubicin—testicular cancer	4.28e-05	0.000405	CcSEcCtD
Ibuprofen—Rash—Cisplatin—testicular cancer	4.27e-05	0.000404	CcSEcCtD
Ibuprofen—Dermatitis—Cisplatin—testicular cancer	4.26e-05	0.000403	CcSEcCtD
Ibuprofen—Malnutrition—Epirubicin—testicular cancer	4.26e-05	0.000403	CcSEcCtD
Ibuprofen—Erythema—Epirubicin—testicular cancer	4.26e-05	0.000403	CcSEcCtD
Ibuprofen—Diarrhoea—Etoposide—testicular cancer	4.24e-05	0.000401	CcSEcCtD
Ibuprofen—Ill-defined disorder—Methotrexate—testicular cancer	4.22e-05	0.000399	CcSEcCtD
Ibuprofen—Tinnitus—Doxorubicin—testicular cancer	4.22e-05	0.000399	CcSEcCtD
Ibuprofen—Anaemia—Methotrexate—testicular cancer	4.2e-05	0.000398	CcSEcCtD
Ibuprofen—Flatulence—Epirubicin—testicular cancer	4.19e-05	0.000397	CcSEcCtD
Ibuprofen—Tension—Epirubicin—testicular cancer	4.18e-05	0.000395	CcSEcCtD
Ibuprofen—Dysgeusia—Epirubicin—testicular cancer	4.17e-05	0.000394	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—KITLG—testicular cancer	4.16e-05	0.00181	CbGpPWpGaD
Ibuprofen—Nervousness—Epirubicin—testicular cancer	4.13e-05	0.000391	CcSEcCtD
Ibuprofen—Malaise—Methotrexate—testicular cancer	4.1e-05	0.000388	CcSEcCtD
Ibuprofen—Dizziness—Etoposide—testicular cancer	4.1e-05	0.000388	CcSEcCtD
Ibuprofen—Muscle spasms—Epirubicin—testicular cancer	4.09e-05	0.000387	CcSEcCtD
Ibuprofen—Immune system disorder—Doxorubicin—testicular cancer	4.09e-05	0.000387	CcSEcCtD
Ibuprofen—Vertigo—Methotrexate—testicular cancer	4.09e-05	0.000387	CcSEcCtD
Ibuprofen—Mediastinal disorder—Doxorubicin—testicular cancer	4.08e-05	0.000386	CcSEcCtD
Ibuprofen—Leukopenia—Methotrexate—testicular cancer	4.07e-05	0.000385	CcSEcCtD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.07e-05	0.00177	CbGpPWpGaD
Ibuprofen—Chills—Doxorubicin—testicular cancer	4.06e-05	0.000384	CcSEcCtD
Ibuprofen—Arrhythmia—Doxorubicin—testicular cancer	4.04e-05	0.000382	CcSEcCtD
Ibuprofen—Nausea—Cisplatin—testicular cancer	4.02e-05	0.00038	CcSEcCtD
Ibuprofen—BCL2—Immune System—BCL10—testicular cancer	4.02e-05	0.00175	CbGpPWpGaD
Ibuprofen—Vision blurred—Epirubicin—testicular cancer	4.01e-05	0.00038	CcSEcCtD
Ibuprofen—Alopecia—Doxorubicin—testicular cancer	4e-05	0.000378	CcSEcCtD
Ibuprofen—Cough—Methotrexate—testicular cancer	3.97e-05	0.000376	CcSEcCtD
Ibuprofen—Mental disorder—Doxorubicin—testicular cancer	3.96e-05	0.000375	CcSEcCtD
Ibuprofen—Ill-defined disorder—Epirubicin—testicular cancer	3.95e-05	0.000374	CcSEcCtD
Ibuprofen—Convulsion—Methotrexate—testicular cancer	3.94e-05	0.000373	CcSEcCtD
Ibuprofen—Vomiting—Etoposide—testicular cancer	3.94e-05	0.000373	CcSEcCtD
Ibuprofen—Erythema—Doxorubicin—testicular cancer	3.94e-05	0.000373	CcSEcCtD
Ibuprofen—Malnutrition—Doxorubicin—testicular cancer	3.94e-05	0.000373	CcSEcCtD
Ibuprofen—Anaemia—Epirubicin—testicular cancer	3.93e-05	0.000372	CcSEcCtD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.92e-05	0.0017	CbGpPWpGaD
Ibuprofen—Agitation—Epirubicin—testicular cancer	3.91e-05	0.00037	CcSEcCtD
Ibuprofen—Rash—Etoposide—testicular cancer	3.91e-05	0.00037	CcSEcCtD
Ibuprofen—Dermatitis—Etoposide—testicular cancer	3.9e-05	0.000369	CcSEcCtD
Ibuprofen—Headache—Etoposide—testicular cancer	3.88e-05	0.000367	CcSEcCtD
Ibuprofen—Flatulence—Doxorubicin—testicular cancer	3.88e-05	0.000367	CcSEcCtD
Ibuprofen—Arthralgia—Methotrexate—testicular cancer	3.87e-05	0.000366	CcSEcCtD
Ibuprofen—Myalgia—Methotrexate—testicular cancer	3.87e-05	0.000366	CcSEcCtD
Ibuprofen—Tension—Doxorubicin—testicular cancer	3.86e-05	0.000366	CcSEcCtD
Ibuprofen—Dysgeusia—Doxorubicin—testicular cancer	3.86e-05	0.000365	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	3.85e-05	0.000364	CcSEcCtD
Ibuprofen—Malaise—Epirubicin—testicular cancer	3.84e-05	0.000363	CcSEcCtD
Ibuprofen—Discomfort—Methotrexate—testicular cancer	3.83e-05	0.000362	CcSEcCtD
Ibuprofen—Nervousness—Doxorubicin—testicular cancer	3.83e-05	0.000362	CcSEcCtD
Ibuprofen—Vertigo—Epirubicin—testicular cancer	3.82e-05	0.000362	CcSEcCtD
Ibuprofen—Syncope—Epirubicin—testicular cancer	3.82e-05	0.000361	CcSEcCtD
Ibuprofen—Leukopenia—Epirubicin—testicular cancer	3.81e-05	0.000361	CcSEcCtD
Ibuprofen—Muscle spasms—Doxorubicin—testicular cancer	3.79e-05	0.000358	CcSEcCtD
Ibuprofen—Palpitations—Epirubicin—testicular cancer	3.76e-05	0.000356	CcSEcCtD
Ibuprofen—Confusional state—Methotrexate—testicular cancer	3.74e-05	0.000354	CcSEcCtD
Ibuprofen—Loss of consciousness—Epirubicin—testicular cancer	3.74e-05	0.000354	CcSEcCtD
Ibuprofen—Cough—Epirubicin—testicular cancer	3.71e-05	0.000351	CcSEcCtD
Ibuprofen—Anaphylactic shock—Methotrexate—testicular cancer	3.71e-05	0.000351	CcSEcCtD
Ibuprofen—Vision blurred—Doxorubicin—testicular cancer	3.71e-05	0.000351	CcSEcCtD
Ibuprofen—Convulsion—Epirubicin—testicular cancer	3.69e-05	0.000349	CcSEcCtD
Ibuprofen—Infection—Methotrexate—testicular cancer	3.69e-05	0.000349	CcSEcCtD
Ibuprofen—Nausea—Etoposide—testicular cancer	3.68e-05	0.000348	CcSEcCtD
Ibuprofen—Hypertension—Epirubicin—testicular cancer	3.67e-05	0.000348	CcSEcCtD
Ibuprofen—Ill-defined disorder—Doxorubicin—testicular cancer	3.65e-05	0.000346	CcSEcCtD
Ibuprofen—Nervous system disorder—Methotrexate—testicular cancer	3.64e-05	0.000344	CcSEcCtD
Ibuprofen—Anaemia—Doxorubicin—testicular cancer	3.64e-05	0.000344	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methotrexate—testicular cancer	3.63e-05	0.000344	CcSEcCtD
Ibuprofen—Arthralgia—Epirubicin—testicular cancer	3.62e-05	0.000343	CcSEcCtD
Ibuprofen—Myalgia—Epirubicin—testicular cancer	3.62e-05	0.000343	CcSEcCtD
Ibuprofen—Agitation—Doxorubicin—testicular cancer	3.62e-05	0.000343	CcSEcCtD
Ibuprofen—Anxiety—Epirubicin—testicular cancer	3.61e-05	0.000342	CcSEcCtD
Ibuprofen—Skin disorder—Methotrexate—testicular cancer	3.61e-05	0.000341	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	3.6e-05	0.000341	CcSEcCtD
Ibuprofen—Hyperhidrosis—Methotrexate—testicular cancer	3.59e-05	0.00034	CcSEcCtD
Ibuprofen—Discomfort—Epirubicin—testicular cancer	3.58e-05	0.000339	CcSEcCtD
Ibuprofen—UGT2B4—Metabolism—STK11—testicular cancer	3.56e-05	0.00155	CbGpPWpGaD
Ibuprofen—Malaise—Doxorubicin—testicular cancer	3.55e-05	0.000336	CcSEcCtD
Ibuprofen—Dry mouth—Epirubicin—testicular cancer	3.54e-05	0.000335	CcSEcCtD
Ibuprofen—Vertigo—Doxorubicin—testicular cancer	3.54e-05	0.000335	CcSEcCtD
Ibuprofen—Anorexia—Methotrexate—testicular cancer	3.54e-05	0.000335	CcSEcCtD
Ibuprofen—Syncope—Doxorubicin—testicular cancer	3.53e-05	0.000334	CcSEcCtD
Ibuprofen—Leukopenia—Doxorubicin—testicular cancer	3.53e-05	0.000334	CcSEcCtD
Ibuprofen—Confusional state—Epirubicin—testicular cancer	3.5e-05	0.000331	CcSEcCtD
Ibuprofen—Palpitations—Doxorubicin—testicular cancer	3.48e-05	0.000329	CcSEcCtD
Ibuprofen—Anaphylactic shock—Epirubicin—testicular cancer	3.47e-05	0.000329	CcSEcCtD
Ibuprofen—Oedema—Epirubicin—testicular cancer	3.47e-05	0.000329	CcSEcCtD
Ibuprofen—Hypotension—Methotrexate—testicular cancer	3.47e-05	0.000328	CcSEcCtD
Ibuprofen—Loss of consciousness—Doxorubicin—testicular cancer	3.46e-05	0.000328	CcSEcCtD
Ibuprofen—Infection—Epirubicin—testicular cancer	3.45e-05	0.000327	CcSEcCtD
Ibuprofen—Cough—Doxorubicin—testicular cancer	3.44e-05	0.000325	CcSEcCtD
Ibuprofen—Shock—Epirubicin—testicular cancer	3.42e-05	0.000323	CcSEcCtD
Ibuprofen—Convulsion—Doxorubicin—testicular cancer	3.41e-05	0.000323	CcSEcCtD
Ibuprofen—Nervous system disorder—Epirubicin—testicular cancer	3.41e-05	0.000322	CcSEcCtD
Ibuprofen—Thrombocytopenia—Epirubicin—testicular cancer	3.4e-05	0.000322	CcSEcCtD
Ibuprofen—Hypertension—Doxorubicin—testicular cancer	3.4e-05	0.000322	CcSEcCtD
Ibuprofen—Tachycardia—Epirubicin—testicular cancer	3.39e-05	0.000321	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methotrexate—testicular cancer	3.38e-05	0.00032	CcSEcCtD
Ibuprofen—Skin disorder—Epirubicin—testicular cancer	3.37e-05	0.000319	CcSEcCtD
Ibuprofen—Hyperhidrosis—Epirubicin—testicular cancer	3.36e-05	0.000318	CcSEcCtD
Ibuprofen—Insomnia—Methotrexate—testicular cancer	3.36e-05	0.000318	CcSEcCtD
Ibuprofen—Arthralgia—Doxorubicin—testicular cancer	3.35e-05	0.000317	CcSEcCtD
Ibuprofen—Myalgia—Doxorubicin—testicular cancer	3.35e-05	0.000317	CcSEcCtD
Ibuprofen—Anxiety—Doxorubicin—testicular cancer	3.34e-05	0.000316	CcSEcCtD
Ibuprofen—Paraesthesia—Methotrexate—testicular cancer	3.33e-05	0.000315	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	3.33e-05	0.000315	CcSEcCtD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.32e-05	0.00144	CbGpPWpGaD
Ibuprofen—Discomfort—Doxorubicin—testicular cancer	3.31e-05	0.000313	CcSEcCtD
Ibuprofen—Anorexia—Epirubicin—testicular cancer	3.31e-05	0.000313	CcSEcCtD
Ibuprofen—Dyspnoea—Methotrexate—testicular cancer	3.31e-05	0.000313	CcSEcCtD
Ibuprofen—Somnolence—Methotrexate—testicular cancer	3.3e-05	0.000312	CcSEcCtD
Ibuprofen—Dry mouth—Doxorubicin—testicular cancer	3.28e-05	0.00031	CcSEcCtD
Ibuprofen—Dyspepsia—Methotrexate—testicular cancer	3.27e-05	0.000309	CcSEcCtD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	3.25e-05	0.00141	CbGpPWpGaD
Ibuprofen—Hypotension—Epirubicin—testicular cancer	3.25e-05	0.000307	CcSEcCtD
Ibuprofen—Confusional state—Doxorubicin—testicular cancer	3.24e-05	0.000307	CcSEcCtD
Ibuprofen—Decreased appetite—Methotrexate—testicular cancer	3.23e-05	0.000305	CcSEcCtD
Ibuprofen—Anaphylactic shock—Doxorubicin—testicular cancer	3.21e-05	0.000304	CcSEcCtD
Ibuprofen—Oedema—Doxorubicin—testicular cancer	3.21e-05	0.000304	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Methotrexate—testicular cancer	3.2e-05	0.000303	CcSEcCtD
Ibuprofen—Fatigue—Methotrexate—testicular cancer	3.2e-05	0.000303	CcSEcCtD
Ibuprofen—Infection—Doxorubicin—testicular cancer	3.19e-05	0.000302	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Epirubicin—testicular cancer	3.16e-05	0.0003	CcSEcCtD
Ibuprofen—Shock—Doxorubicin—testicular cancer	3.16e-05	0.000299	CcSEcCtD
Ibuprofen—Nervous system disorder—Doxorubicin—testicular cancer	3.15e-05	0.000298	CcSEcCtD
Ibuprofen—Thrombocytopenia—Doxorubicin—testicular cancer	3.15e-05	0.000298	CcSEcCtD
Ibuprofen—Insomnia—Epirubicin—testicular cancer	3.14e-05	0.000297	CcSEcCtD
Ibuprofen—Tachycardia—Doxorubicin—testicular cancer	3.14e-05	0.000297	CcSEcCtD
Ibuprofen—Skin disorder—Doxorubicin—testicular cancer	3.12e-05	0.000295	CcSEcCtD
Ibuprofen—Paraesthesia—Epirubicin—testicular cancer	3.12e-05	0.000295	CcSEcCtD
Ibuprofen—Hyperhidrosis—Doxorubicin—testicular cancer	3.11e-05	0.000294	CcSEcCtD
Ibuprofen—Dyspnoea—Epirubicin—testicular cancer	3.1e-05	0.000293	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—FGFR3—testicular cancer	3.09e-05	0.00134	CbGpPWpGaD
Ibuprofen—Somnolence—Epirubicin—testicular cancer	3.09e-05	0.000292	CcSEcCtD
Ibuprofen—Anorexia—Doxorubicin—testicular cancer	3.06e-05	0.00029	CcSEcCtD
Ibuprofen—Feeling abnormal—Methotrexate—testicular cancer	3.06e-05	0.000289	CcSEcCtD
Ibuprofen—Dyspepsia—Epirubicin—testicular cancer	3.06e-05	0.000289	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Methotrexate—testicular cancer	3.04e-05	0.000287	CcSEcCtD
Ibuprofen—Decreased appetite—Epirubicin—testicular cancer	3.02e-05	0.000286	CcSEcCtD
Ibuprofen—Hypotension—Doxorubicin—testicular cancer	3e-05	0.000284	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Epirubicin—testicular cancer	3e-05	0.000284	CcSEcCtD
Ibuprofen—Fatigue—Epirubicin—testicular cancer	2.99e-05	0.000283	CcSEcCtD
Ibuprofen—Constipation—Epirubicin—testicular cancer	2.97e-05	0.000281	CcSEcCtD
Ibuprofen—Urticaria—Methotrexate—testicular cancer	2.95e-05	0.000279	CcSEcCtD
Ibuprofen—Abdominal pain—Methotrexate—testicular cancer	2.93e-05	0.000278	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Doxorubicin—testicular cancer	2.93e-05	0.000277	CcSEcCtD
Ibuprofen—Insomnia—Doxorubicin—testicular cancer	2.91e-05	0.000275	CcSEcCtD
Ibuprofen—Paraesthesia—Doxorubicin—testicular cancer	2.89e-05	0.000273	CcSEcCtD
Ibuprofen—Dyspnoea—Doxorubicin—testicular cancer	2.87e-05	0.000271	CcSEcCtD
Ibuprofen—Feeling abnormal—Epirubicin—testicular cancer	2.86e-05	0.000271	CcSEcCtD
Ibuprofen—Somnolence—Doxorubicin—testicular cancer	2.86e-05	0.00027	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Epirubicin—testicular cancer	2.84e-05	0.000269	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—KIT—testicular cancer	2.84e-05	0.00123	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—H2AFZ—testicular cancer	2.84e-05	0.00123	CbGpPWpGaD
Ibuprofen—Dyspepsia—Doxorubicin—testicular cancer	2.83e-05	0.000268	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—STK11—testicular cancer	2.82e-05	0.00123	CbGpPWpGaD
Ibuprofen—Decreased appetite—Doxorubicin—testicular cancer	2.79e-05	0.000264	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Doxorubicin—testicular cancer	2.77e-05	0.000263	CcSEcCtD
Ibuprofen—Fatigue—Doxorubicin—testicular cancer	2.77e-05	0.000262	CcSEcCtD
Ibuprofen—Urticaria—Epirubicin—testicular cancer	2.76e-05	0.000261	CcSEcCtD
Ibuprofen—Constipation—Doxorubicin—testicular cancer	2.75e-05	0.00026	CcSEcCtD
Ibuprofen—Abdominal pain—Epirubicin—testicular cancer	2.75e-05	0.00026	CcSEcCtD
Ibuprofen—Hypersensitivity—Methotrexate—testicular cancer	2.73e-05	0.000259	CcSEcCtD
Ibuprofen—Asthenia—Methotrexate—testicular cancer	2.66e-05	0.000252	CcSEcCtD
Ibuprofen—Feeling abnormal—Doxorubicin—testicular cancer	2.65e-05	0.000251	CcSEcCtD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.63e-05	0.00114	CbGpPWpGaD
Ibuprofen—Gastrointestinal pain—Doxorubicin—testicular cancer	2.63e-05	0.000249	CcSEcCtD
Ibuprofen—Pruritus—Methotrexate—testicular cancer	2.63e-05	0.000249	CcSEcCtD
Ibuprofen—UGT1A3—Metabolism—HPGDS—testicular cancer	2.62e-05	0.00114	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—KITLG—testicular cancer	2.61e-05	0.00113	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Epirubicin—testicular cancer	2.56e-05	0.000242	CcSEcCtD
Ibuprofen—Urticaria—Doxorubicin—testicular cancer	2.55e-05	0.000242	CcSEcCtD
Ibuprofen—Abdominal pain—Doxorubicin—testicular cancer	2.54e-05	0.00024	CcSEcCtD
Ibuprofen—Diarrhoea—Methotrexate—testicular cancer	2.54e-05	0.00024	CcSEcCtD
Ibuprofen—Asthenia—Epirubicin—testicular cancer	2.49e-05	0.000236	CcSEcCtD
Ibuprofen—Pruritus—Epirubicin—testicular cancer	2.46e-05	0.000233	CcSEcCtD
Ibuprofen—Dizziness—Methotrexate—testicular cancer	2.45e-05	0.000232	CcSEcCtD
Ibuprofen—BCL2—Immune System—KITLG—testicular cancer	2.42e-05	0.00105	CbGpPWpGaD
Ibuprofen—Diarrhoea—Epirubicin—testicular cancer	2.38e-05	0.000225	CcSEcCtD
Ibuprofen—Hypersensitivity—Doxorubicin—testicular cancer	2.37e-05	0.000224	CcSEcCtD
Ibuprofen—Vomiting—Methotrexate—testicular cancer	2.36e-05	0.000223	CcSEcCtD
Ibuprofen—Rash—Methotrexate—testicular cancer	2.34e-05	0.000221	CcSEcCtD
Ibuprofen—Dermatitis—Methotrexate—testicular cancer	2.34e-05	0.000221	CcSEcCtD
Ibuprofen—Headache—Methotrexate—testicular cancer	2.33e-05	0.00022	CcSEcCtD
Ibuprofen—Asthenia—Doxorubicin—testicular cancer	2.31e-05	0.000218	CcSEcCtD
Ibuprofen—Dizziness—Epirubicin—testicular cancer	2.3e-05	0.000217	CcSEcCtD
Ibuprofen—Pruritus—Doxorubicin—testicular cancer	2.27e-05	0.000215	CcSEcCtD
Ibuprofen—UGT2B7—Metabolism—HPGDS—testicular cancer	2.23e-05	0.000969	CbGpPWpGaD
Ibuprofen—Vomiting—Epirubicin—testicular cancer	2.21e-05	0.000209	CcSEcCtD
Ibuprofen—Nausea—Methotrexate—testicular cancer	2.2e-05	0.000209	CcSEcCtD
Ibuprofen—Diarrhoea—Doxorubicin—testicular cancer	2.2e-05	0.000208	CcSEcCtD
Ibuprofen—Rash—Epirubicin—testicular cancer	2.19e-05	0.000207	CcSEcCtD
Ibuprofen—Dermatitis—Epirubicin—testicular cancer	2.19e-05	0.000207	CcSEcCtD
Ibuprofen—Headache—Epirubicin—testicular cancer	2.18e-05	0.000206	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—MMP2—testicular cancer	2.16e-05	0.000936	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.14e-05	0.000931	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.13e-05	0.000926	CbGpPWpGaD
Ibuprofen—Dizziness—Doxorubicin—testicular cancer	2.13e-05	0.000201	CcSEcCtD
Ibuprofen—CXCL8—Metabolism of proteins—MMP2—testicular cancer	2.11e-05	0.000917	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—HPGDS—testicular cancer	2.11e-05	0.000916	CbGpPWpGaD
Ibuprofen—Nausea—Epirubicin—testicular cancer	2.06e-05	0.000195	CcSEcCtD
Ibuprofen—Vomiting—Doxorubicin—testicular cancer	2.04e-05	0.000193	CcSEcCtD
Ibuprofen—Rash—Doxorubicin—testicular cancer	2.03e-05	0.000192	CcSEcCtD
Ibuprofen—Dermatitis—Doxorubicin—testicular cancer	2.02e-05	0.000192	CcSEcCtD
Ibuprofen—Headache—Doxorubicin—testicular cancer	2.01e-05	0.000191	CcSEcCtD
Ibuprofen—PPARG—Gene Expression—H2AFZ—testicular cancer	1.98e-05	0.000861	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—HPGDS—testicular cancer	1.94e-05	0.000844	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—FGFR3—testicular cancer	1.94e-05	0.000843	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.91e-05	0.000831	CbGpPWpGaD
Ibuprofen—Nausea—Doxorubicin—testicular cancer	1.91e-05	0.000181	CcSEcCtD
Ibuprofen—UGT1A3—Metabolism—STK11—testicular cancer	1.91e-05	0.000828	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—HPGDS—testicular cancer	1.81e-05	0.000787	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—HPGDS—testicular cancer	1.81e-05	0.000787	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—FGFR3—testicular cancer	1.8e-05	0.000782	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—KIT—testicular cancer	1.78e-05	0.000774	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—HPGDS—testicular cancer	1.75e-05	0.000759	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.74e-05	0.000758	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—KIT—testicular cancer	1.65e-05	0.000718	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—H2AFZ—testicular cancer	1.64e-05	0.000711	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—STK11—testicular cancer	1.63e-05	0.000707	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—STK11—testicular cancer	1.62e-05	0.000704	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—STK11—testicular cancer	1.53e-05	0.000666	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—H2AFZ—testicular cancer	1.52e-05	0.000662	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—KITLG—testicular cancer	1.51e-05	0.000654	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—HPGDS—testicular cancer	1.48e-05	0.000642	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—STK11—testicular cancer	1.41e-05	0.000613	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—KITLG—testicular cancer	1.4e-05	0.000609	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—STK11—testicular cancer	1.32e-05	0.000572	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—STK11—testicular cancer	1.32e-05	0.000572	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—STK11—testicular cancer	1.27e-05	0.000552	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—HPGDS—testicular cancer	1.17e-05	0.000509	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—FGFR3—testicular cancer	1.12e-05	0.000486	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—STK11—testicular cancer	1.07e-05	0.000466	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—FGFR3—testicular cancer	1.04e-05	0.000453	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—KIT—testicular cancer	1.03e-05	0.000446	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—H2AFZ—testicular cancer	1.02e-05	0.000445	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—KIT—testicular cancer	9.57e-06	0.000416	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—HPGDS—testicular cancer	9.54e-06	0.000415	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—HPGDS—testicular cancer	9.49e-06	0.000412	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—KITLG—testicular cancer	9.41e-06	0.000409	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—STK11—testicular cancer	8.52e-06	0.00037	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—HPGDS—testicular cancer	8.52e-06	0.00037	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—HPGDS—testicular cancer	8.31e-06	0.000361	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—HPGDS—testicular cancer	7.77e-06	0.000337	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—FGFR3—testicular cancer	7e-06	0.000304	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—STK11—testicular cancer	6.93e-06	0.000301	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—STK11—testicular cancer	6.89e-06	0.000299	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—KIT—testicular cancer	6.42e-06	0.000279	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—STK11—testicular cancer	6.19e-06	0.000269	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—STK11—testicular cancer	6.04e-06	0.000262	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—STK11—testicular cancer	5.64e-06	0.000245	CbGpPWpGaD
